Inix clarifies/sues publisher over media report on “unsubmitted” NPRA application

INIX Technologies Holdings Bhd has clarified that its application for the registration with the Malaysian National Pharmaceutical Regulatory Agency (NPRA) has been submitted but is pending additional information as per the latter’s request.

The ACE Market-listed software company courted controversy over a media report today that it had not made an application to NPRA despite the company’s Bursa Malaysia filing on Jan 13 claiming that it had done so.

“The application was made by INIX and received by NPRA on Jan 11,” the company pointed out in a media statement. “The authority has since requested additional information in relation to the application.”

Elaborating further INIX noted that the group is in the midst of preparing the additional information requested by NPRA.

“We hope that this would clear the air and that our media friends would seek us for clarification in the future,” added the company.

In its CEO Morning Brief today, The Edge reported that Health director-general Tan Sri Dr Noor Hisham Abdullah when approached had said the authority has yet to receive an application from INIX.

According to the business portal, the only company that has thus far received conditional registration from the NPRA for its COVID-19 vaccine is Pfizer, as updated by Science, Technology and Innovation Minister Khairy Jamaluddin last week.

Meanwhile, in a filing to Bursa Malaysia after the close of today’s trading, INIX said it is taking legal action against the publisher in light of the seriousness of the implication arising from the article entitled INIX Technologies’ Application to Supply COVID-19 Vaccines Yet to be Received by NPRA.

“INIX Technologies Holdings Bhd has instructed its lawyer to seek appropriate legal recourse which shall include a demand from the author and the publisher of the article to retract the misleading and damaging statement, and to publish an appropriate apology and clarification,” noted the company.

“The company will also seek an undertaking that the author and publisher of the article shall not repeat the statements in any form.”

In view of the above matter, trading of INIX’s shares was halted for an hour from 3.09pm to 4.09pm today.

At the close of today’s trading, Inix was up 5.5 sen or 17.46% to 37 sen with 53.11 million shares traded, thus valuing the company at RM173 mil. – Jan 20, 2021

Subscribe and get top news delivered to your Inbox everyday for FREE